Argentine hemorrhagic fever (AHF) is a potentially lethal infection in Argentina. The case-fatality ratio is ú15%, but treatment reduces the mortality rate to õ1%. Diagnosis is based on clinical and laboratory criteria, but no case definition has been validated. A chart review was conducted for patients hospitalized with suspected AHF. Individuals with a fourfold rise in antibody titer were classified as cases. The combination of a platelet count of õ100,000/mm 3 and a white blood cell (WBC) count of õ2,500/mm 3 had a sensitivity and specificity of 87% and 88%, respectively, thus suggesting that the use of these criteria in a case definition would be helpful for epidemiological studies of AHF. The combination of a platelet count of õ100,000/mm 3 and a WBC count of õ4,000/mm 3 had a sensitivity of 100% and a specificity of 71%; the use of these criteria in a case definition should be helpful for screening patients for therapy with immune plasma in the region where AHF is endemic.
Arenaviruses are important causes of hemorrhagic fever synbrain and other tissues. Calomys musculinus and Calomys laucha are the principal reservoirs of Junin virus; these field rodromes worldwide [1] . Argentine hemorrhagic fever (AHF) was first recognized in the 1950s and is an acute arenavirus dents are believed to transmit the organism to humans via infectious aerosol and direct contact during farming activities infection caused by Junin virus [2] . AHF is a major public health problem in agricultural workers in the area of Argentina [5, 6] . The finding that an attenuated AHF vaccine was safe and immunogenic in nonhuman primates and humans lead to where it is endemic, with 100 -800 recognized cases of AHF each year before the advent of immunization of high-risk indithe implementation of a large randomized, double-blind, placebo-controlled vaccine efficacy trial in the region of Argentina viduals [3] . Initial symptoms are fever and myalgia frequently accompanied by mild hypotension, conjunctivitis, and petewhere AHF is endemic [7 -10] . In conjunction with this trial, we conducted a study to develop practical case definitions of chiae in the axilla, soft palate, and gingival margin. Neurological signs including irritability, lethargy, and hyporeflexia are AHF for use as objective outcome measures, to provide an objective basis for decisions about therapy, and to explore the common. Patients with severe infection may develop extensive hemorrhagic manifestations, shock, and seizures. The caseutility of the case definitions for predicting which patients would benefit from treatment with immune plasma. fatality ratio among untreated patients is 15% -30%.
Early treatment with plasma from patients who have recovered from AHF reduces the mortality rate to õ1%, but this treatment is complicated by a late neurological syndrome of Methods undetermined origin in 10% of survivors [4] . Pathological exSubjects were selected for this study from a random sample amination of fatal AHF cases shows bone marrow and of patients admitted to Instituto Nacional de Enfermedades lymphoid necrosis accompanied by vascular changes in the Virales Humanas (INEVH) in Pergamino, Argentina, during the 1986 -1990 seasons for whom complete clinical data were available for review and from whom acute-and convalescent- (acute-phase serum) and serum was obtained during the convalescent period (convalescent-phase serum). Data abstracted by retrospective review of the medical record included signs and symptoms characteristic of AHF and pertiStatistical analysis. The data were analyzed by using nent laboratory data, such as the minimum platelet and WBC Epi Info Version 6 (USD, Stone Mountain, GA). The sensitivity counts and maximum urinary protein excretion [11] . Clinical and specificity of individual combinations of signs and sympinformation was entered into the chart before Junin virus seroltoms were assessed for the serologically confirmed cases and ogy was performed; the laboratory technicians performing the controls, respectively. Differences in proportions were anaserologies were unaware of the clinical status of patients. lyzed using the x 2 and Fisher's exact tests. The Kruskal-Wallis A case of AHF was defined as a patient with an admission test was used for comparison of means. diagnosis of suspected AHF and a fourfold rise in the titer of neutralizing antibody to Junin virus between the time that acute-and convalescent-phase serum specimens were obtained.
Results Controls were subjects with an admission diagnosis of suspected AHF but for whom serological evidence of Junin virus
Of the 55 subjects admitted to INEVH with suspected AHF infection was not found.
who were selected for the study, 31 (56%) met the laboratory The sensitivity and specificity of individual signs and sympcase definition for AHF and were classified as cases. The 24 toms were determined; variables with relatively high sensitivity subjects (44%) without serological evidence for AHF were and specificity were combined and evaluated. For clinical use, classified as controls. The mean ages for the cases and controls preference was given to sensitivity to avoid excluding cases in were 39 years and 34 years, respectively (P Å .3). Of the cases, which failure to treat with immune plasma could result in a 81% were male vs. 79% of the controls. The mean WBC counts severe or fatal illness. For use in the vaccine trial, a case for the cases and controls were 1,813/mm 3 and 3,202/mm 3 , definition associated with the highest overall sensitivity and respectively (P Å .0001), while the mean platelet count was specificity was sought to provide an accurate and precise esti-77,000/mm 3 for the cases and 121,000/mm 3 for the controls mate of vaccine efficacy.
(P Å .000001). Twenty-eight cases (90%) and 14 controls Laboratory methods. Determination of WBC and platelet (58%) received therapy with immune plasma (P Å .01). counts and urinary protein excretion was performed manually
Of the clinical signs and symptoms evaluated at admission, on site by using a hemocytometric chamber [12] . Titers of axillary petechiae and lack of upper respiratory tract symptoms serum neutralizing antibodies to Junin virus were measured by were significantly more common in cases than in controls (table using a complement-enhanced plaque-reduction neutralization 1). Other criteria evaluated included coma, confusion, convultest as previously described [13] . Briefly, fourfold dilutions (in sions, delirium, emotional excitation, dizziness, gastrointestinal Hanks balanced salt solution [HBSS] with 1% 1 M HEPES bleeding, hemoptysis, and epistaxis. However, each of these and 50 mg of gentamicin/mL) of heat-inactivated sera were symptoms occurred in õ10% of cases, which precluded a added to wells of a microtiter plate, beginning at a 1:2 dilution. meaningful analysis. Working suspensions of the virus for the sensitized test were
Of laboratory criteria, a WBC count of õ2,500/mm 3 , a platecreated by diluting Candid no. 1 in serum diluent to which let count of õ100,000/mm 3 , and urinary protein excretion of freeze-dried guinea pig complement (Low Tox; Cedarlane Lab- §1 g/L were all significantly associated with AHF, but proteinoratories, Hornby, Ontario, Canada) was added. After thorough uria was found only in 42% of cases (table 1) . A WBC count mixing, test serum-virus suspensions and virus controls were of õ2,500/mm 3 and a platelet count of õ100,000/mm 3 in comincubated at 36ЊC for 2 hours in 5% CO 2 . Duplicate samples bination had a high sensitivity (87%) and specificity (88%) at each dilution, together with similarly diluted virus controls, (table 2), thus suggesting that these criteria would be useful for were adsorbed onto 2-day-old Vero cell monolayers (10 5 cells identification of AHF cases (e.g., identifying cases in vaccine per well) for 1 hour at room temperature. efficacy trials). The combination of a platelet count of An initial 1-mL overlay (0.5% agarose in HBSS with 1% õ100,000/mm 3 and a WBC count of õ4,000/mm 3 had a sensi-HEPES, 2% HIFCS [heat inactivated fetal calf serum], and 50 tivity of 100% and a specificity of 71%. Use of these criteria mg of gentamicin/mL) was applied to each well, and plates in a case definition should be helpful in screening patients for were incubated at 36ЊC in 5% CO 2 for 4 days. A second therapy with immune plasma in the region of Argentina where 1-mL overlay (5% agarose in HBSS with 1% 1 M HEPES, 1%
AHF is endemic. The addition of axillary petechiae and lack HIFCS, 50 mg of gentamicin/mL, and 1:10,000 [final concenof upper respiratory tract symptoms did not enhance the sensitration] neutral red) was applied, plates were incubated at 36ЊC in 5% CO 2 for 24 hours, and an 80% reduction of plaque counts tivity and specificity of these case definitions.
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Discussion
in the area where AHF is endemic. In this study, we found that a relatively simple combination of laboratory tests provided The insidious onset of AHF, together with its frequently case definitions AHF for clinical studies and for screening nonspecific presentation, makes distinguishing this potentially patients for treatment with immune plasma. fatal infection from other viral and bacterial diseases difficult Simple screening criteria have previously been found to be on the basis of clinical grounds. The imperative for early diaguseful for the diagnosis of AHF as well as other severe viral nosis is driven by the requirement to administer potentially diseases and hemorrhagic fevers [16, 17] . In a study of febrile lifesaving immune plasma therapy within 8 days of disease patients with suspected AHF in Pergamino, Argentina, during onset [4, 14] . Classical serological and virus cultivation tech-1966 -1967, Schwarz et al. [11] found that the simultaneous niques both are technically demanding and do not provide presence of weakness, dizziness, cutaneous petechiae, and conresults in a timely fashion [15] . Newer tests such as antigenjunctival congestion correctly identified 71.3% of patients subcapture immunoassay and molecular-based methodologies, sequently proven to have the disease, while misidentifying only while offering great promise for rapid diagnosis, remain in the 3.4%. Useful screening laboratory criteria included thrombocydevelopmental stages and are unlikely to find widespread utility topenia, the presence of casts in the urinary sediment, and extreme leukopenia [11] . In this study, we showed that simple combinations of leukopenia and thrombocytopenia were useful (/mm 3 ) õ200,000 õ150,000 õ100,000 õ80,000
The lack of 100% specificity of the clinical case definitions could represent infection with other organisms that cause leu- infection would be expected to be lower than that in our study. 
